Race Tied to Outcomes with HF Drug (CME/CE)

(MedPage Today) -- African Americans with heart failure and reduced left ventricular output may not derive the same benefit from spironolactone as other ethnic groups, a post-hoc analysis of the randomized RALES trial found.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news